A pilot study on feasibility, acceptance and effectiveness of metacognitive-oriented social skills training in schizophrenia

  1. Inchausti, F. 7
  2. García-Poveda, N.V. 2
  3. Ballesteros-Prados, A. 3
  4. Fonseca-Pedrero, E. 6
  5. Ortuño-Sierra, J. 6
  6. Sánchez-Reales, S. 4
  7. Prado-Abril, J. 1
  8. Aldaz-Armendáriz, J.A. 5
  9. Mole, J. 8
  1. 1 Aragon Health Sciences Institute (IACS), Complejo Hospitalario of Navarra, CSMIJ Natividad Zubieta, Sarriguren, Research Network on Preventive Activities and Health Promotion (REDIAPP) (RD12/0005), Zaragoza, Spain
  2. 2 CSM Ermitagaña, Complejo Hospitalario of Navarra, Pamplona, Spain
  3. 3 CSM Estella, Complejo Hospitalario of Navarra, Estella, Spain
  4. 4 CSM Jumilla, Virgen del Castillo Hospital, Murcia, Spain
  5. 5 Hospital Miguel Servet
    info

    Hospital Miguel Servet

    Zaragoza, España

    ROR https://ror.org/01r13mt55

  6. 6 Universidad de La Rioja
    info

    Universidad de La Rioja

    Logroño, España

    ROR https://ror.org/0553yr311

  7. 7 Universidad de Navarra
    info

    Universidad de Navarra

    Pamplona, España

    ROR https://ror.org/02rxc7m23

  8. 8 University of Oxford
    info

    University of Oxford

    Oxford, Reino Unido

    ROR https://ror.org/052gg0110

Show affiliations +
Journal:
BMC Psychiatry

ISSN: 1471-244X

Year of publication: 2017

Volume: 17

Issue: 1

Type: Article

DOI: 10.1186/S12888-017-1378-Z SCOPUS: 2-s2.0-85020628125 WoS: WOS:000405812300001 GOOGLE SCHOLAR

More publications in: BMC Psychiatry

Sustainable development goals

Abstract

Background: In preparation for a randomized controlled trial, a pilot study was conducted to investigate the feasibility, acceptability and effectiveness of a psychotherapy group based on metacognitive-oriented social skills training (MOSST). Methods: Twelve outpatients with schizophrenia were offered 16 group-sessions of MOSST. Effect sizes were calculated for changes from baseline to treatment end for both psychosocial functioning and metacognitive abilities measured by the Personal and Social Performance Scale (PSP) and the Metacognition Assessment Scale-Abbreviated (MAS-A) respectively. Results and discussion: Ten patients finished the full treatment protocol and nonsignificant moderate effect sizes were obtained on PSP and MAS-A scores. To date, this is the first study in Spain to suggest that outpatients with schizophrenia will accept metacognitive therapy for social skills training and evidence improvements in psychosocial functioning and metacognition. Conclusion: Despite limitations inherent in a pilot study, including a small sample size and the absence of a control group, sufficient evidence of effectiveness was found to warrant further investigation. Trial registration:ISRCTN10917911. Retrospectively registered 30 November 2016. © 2017 The Author(s).